SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Sean McCarthy will participate on a panel at the Charlotte Biotechnology Conference titled "Financing Successful Biotech Companies", on the campus of UNC-Charlotte.
News | 10. 12. 2007
